Tramadol Hcl Tablet, Extended Release
Product Images NDC 80425-0312

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tramadol Hcl (NDC 80425-0312). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig 1 (Fig 1)

A pharmacokinetic line graph illustrating Tramadol concentration (ng/mL) over 24 hours. It compares Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily (q.d.) and Tramadol Hydrochloride Tablets 50 mg every 6 hours (q6h). The x-axis shows time in hours, and the y-axis shows concentration in ng/mL. Two data series are depicted with solid and open circles.*

FDA Label Image

Fig 2 (Fig 2)

A pharmacokinetic curve showing M1 concentration (ng/mL) over time (hours) comparing Tramadol Hydrochloride Extended-Release Tablets 200 mg q.d. and Tramadol Hydrochloride Tablets 50 mg q6h. The graph plots concentration trends for both formulations within a 24-hour period.*

FDA Label Image

Fig 3 (Fig 3)

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis' showing the percent of patients achieving various levels of response threshold (percent improvement from baseline). Five lines represent different doses of Tramadol Hydrochloride Extended-Release Tablets (100 mg, 200 mg, 300 mg, 400 mg) and placebo. The y-axis shows the percent of patients achieving response, and the x-axis shows response threshold from 0 to 100 percent.*

FDA Label Image

Fig 4 (Fig 4)

A line graph comparing the percentage of patients achieving various levels of response threshold in a study of Tramadol Hydrochloride Extended-Release Tablets versus placebo. The x-axis represents response threshold as percent improvement from baseline, and the y-axis represents percent of patients achieving response. The graph shows higher response rates for Tramadol Hydrochloride Extended-Release Tablets across most thresholds compared to placebo.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Tramadol HCL, showing its molecular components including methoxyphenyl group and tertiary amine with hydrochloride salt.*

FDA Label Image

Label 1 (Tramadol 300mg 80425 0312 01)

Tramadol 300 mg extended-release (ER) tablets packaged by Advanced Rx Pharmacy of Tennessee, LLC. The label is green and yellow, listing the quantity as 30 tablets with storage instructions and a caution note about potential drowsiness. The label also references the NDC 80425-0312 and includes expiration date details.*

FDA Label Image

Label 2 (Tramadol 300mg 80425 0312 02)

Label for Tramadol HCL ER 300 mg extended-release tablets, 24-hour dose, in a package of 60 tablets. The label includes dosing comparison to Ultram, storage instructions at 20-25°C, and manufacturer information from Advanced Rx Pharmacy of Tennessee, LLC and Lupin Pharmaceu. The NDC and expiration date fields are visible but partially redacted.*

FDA Label Image

Label 3 (Tramadol 300mg 80425 0312 03)

Label for Tramadol HCL ER 300 mg extended-release oral tablets, 24-hour formulation, from Advanced Rx Pharmacy of Tennessee, LLC. The label includes storage instructions at 20-25°C, a lot number placeholder, expiration date 8/31/2025, and comparison to the brand Ultram. The NDC shown is 80425-0312.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.